Introduction
============

The cyclobutane structural motif is present in a variety of natural products and pharmaceutical molecules ([Scheme 1](#sch1){ref-type="fig"}).[@cit1],[@cit2] Cyclobutanes are also versatile synthetic intermediates, as the ring strain inherent to these structures engenders them with unique reactivity that can be leveraged in a variety of transformations to build complex frameworks.[@cit3] \[2 + 2\] cycloaddition reactions represent the most extensively developed approach to construct cyclobutanes, and recent advances have given rise to elegant enantioselective reactions.[@cit4] An alternative strategy is to prepare a versatile cyclobutane building block, and then use C--H functionalization or cross-coupling chemistry to elaborate the scaffold in a modular fashion.[@cit5] In this latter approach, a single enantioenriched intermediate can quickly be converted to a variety of more functionalized structures.

![A C--H functionalization strategy to access (+)-rumphellaone A.](c8sc05444d-s1){#sch1}

We recently reported a synthesis of the natural product (+)-psiguadial B (**1**), which featured a tandem Wolff-rearrangement/asymmetric ketene addition to prepare enantioenriched 8-aminoquinolinamide **4** ([Scheme 1](#sch1){ref-type="fig"}).[@cit6] Given the short synthesis of **4** from commercial starting materials, we became interested in further applications of this chiral building block. Specifically, we envisioned that directed C--H arylation could enable diversification at the β-position,[@cit7] while hydrolysis of the 8-aminoquinolinamide followed by decarboxylative radical cross-coupling could enable diversification at the α-position. A number of powerful methods have been developed that leverage the decarboxylative formation of carbon-centered radicals for C--C and C--X bond formation.[@cit8] It was anticipated that the sequence of C--H arylation followed by decarboxylative coupling could provide access to a collection of enantioenriched polyfunctionalized cyclobutanes.

Results and discussion
======================

We began by investigating the scope of the directed C--H arylation of 8-aminoquinolinamide **4**, which was prepared in three steps and 99% ee from commercially available 2,2-dimethylcyclopentan-1-one.[@cit6] Using our previously developed conditions \[Pd(OAc)~2~ (15 mol%), Ag~2~CO~3~ (1.0 equiv.), aryl iodide (2.0 equiv.), TBME, 90 °C\], a series of *cis*-arylated cyclobutanes were prepared in good yields ([Scheme 2](#sch2){ref-type="fig"}).[@cit9] The reaction was compatible with both electron-rich and electron-deficient aryl iodides and tolerated substitution at the *ortho*, *meta*, and *para* positions. Heteroaryl iodides were also found to be competent coupling partners, allowing for incorporation of pyridines, pyrimidines, and indoles. Unfortunately, with 5-iodo-2-phenylpyridine or 5-iodo-2-methoxypyrimidine, the reaction proceeded in only modest yields (\<40%). Aryl triflates failed to react under the optimized reaction conditions.

![Scope of the C--H arylation of **4**. Reactions were conducted on 0.20 mmol scale in a sealed 2-dram vial using Pd(OAc)~2~ (15 mol%), Ag~2~CO~2~ (1.0 equiv.), **5a--p** (2.0 equiv.), \[**4**\] = 0.2 M in TBME. TBME = *tert*-butyl methyl ether.](c8sc05444d-s2){#sch2}

Having established the generality of the C--H arylation step, we turned our attention to diversification at the carbon bearing the 8-aminoquinolinamide through functional group interconversion or decarboxylative cross-coupling. To this end, hydrolysis of **9d** proceeded with epimerization to the thermodynamically favored *trans* diastereomer, delivering *trans*-cyclobutanoic acid **10** ([Scheme 3](#sch3){ref-type="fig"}).[@cit10] Reduction of the acid delivered alcohol **12**, which could be oxidized under Stahl conditions to aldehyde **13**.[@cit11] Alternatively, **10** could be converted to the corresponding acid chloride and engaged in a nickel-catalyzed reductive cross-coupling with iodocyclohexane to access ketone **14**.[@cit12] In order to investigate decarboxylative coupling processes, acid **10** was subjected to EDC-mediated coupling with *N*-hydroxyphthalimide to provide NHP ester **11**.[@cit13] Ni-catalyzed coupling of **11** with arylzinc chloride **15** gave *trans*-diarylcyclobutane **16** in good yield as a single diastereomer.[@cit8d] Similarly, NHP ester **11** underwent Ni-catalyzed reductive alkenylation with styrenyl bromide **17** to furnish cyclobutane **18** in 56% yield.[@cit8c],[@cit8e] Photoinduced decarboxylative borylation of **11** proceeded smoothly to afford boronic ester **20**,[@cit8h] and decarboxylative Minisci type arylation of **11** under photoredox catalysis delivered quinoline **19**.[@cit8i]

![Selected derivatizations of **10**. ABNO = 9-azabicylo\[3.3.1\]nonane *N*-oxyl. NMI = *N*-methylimidazole. NHPI = *N*-hydroxyphthalimide. EDC = 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide. DMAP = 4-dimethylaminopyridine. TFA = trifluoroacetic acid. dtbbpy = di-*tert*-butylbipyridine. dme = dimethoxyethane. 4,4′-MeObpy = 4,4′-dimethoxybipyridine. \[Ir\] = Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~.](c8sc05444d-s3){#sch3}

To further demonstrate the utility of this cyclobutane difunctionalization strategy, we designed and executed a synthesis of the natural product (+)-rumphellaone A (**8**).[@cit14] (+)-Rumphellaone A (**8**) was isolated in 2010 from the gorgonian coral *Rumphella antipathies* and possesses anti-proliferative activity against human T-cell acute lymphoblastic leukemia tumor cells.[@cit2d] Retrosynthetically, we envisioned disconnecting through the C1--C2 bond to give **21** ([Scheme 4](#sch4){ref-type="fig"}); in the forward sense, the ketone fragment would be incorporated through a decarboxylative Giese addition with methyl vinyl ketone. The butenolide of **21** could derive from oxidation of furan **22**, which could be prepared from **4** by a directed C--H arylation. As a proof of concept, 8-aminoquinolinamide **4** was subjected to Pd-catalyzed C--H functionalization with furanyl iodide **23** to give *cis*-cyclobutane **24** in 90% yield.[@cit15] Hydrolysis and subsequent decarboxylative Giese reaction with methyl vinyl ketone under photoredox catalysis provided **25** in 50% yield over two steps.[@cit16]

![Retrosynthetic analysis of **8** and key proof-of-concept study. TMS = trimethylsilyl. MVK = methyl vinylketone.](c8sc05444d-s4){#sch4}

Having validated the feasibility of the two key cyclobutane functionalization reactions, attention turned to the unmasking of the butenolide functionality prior to the decarboxylative Giese reaction. Treatment of **22** with sodium chlorite under buffered conditions[@cit17] delivered 5-hydroxybutenolide **26** ([Scheme 5](#sch5){ref-type="fig"}). The remaining challenge was installation of the C8 methyl substituent with the required *S*-configuration. In prior syntheses of **8**, this stereogenic center was set under the guidance of chiral catalyst control.[@cit14] Given that the C8 diastereomers were inseparable by column chromatography, high diastereoselectivity for this methyl addition was important.

![Synthesis of (+)-rumphellaone A (**8**).](c8sc05444d-s5){#sch5}

After exploring a range of conditions to effect the methylation, we were pleased to discover that either C8 diastereomer (**27** or **28**) could be prepared using the appropriate methyltitanium reagent. Thus, addition of **26** to a pre-formed 1 : 1 mixture of (^i^PrO)~3~ TiCl and MeLi at --78 °C, with warming to 23 °C, delivered the undesired C8 diastereomer, **27**, in 76% yield and 22 : 1 dr.[@cit18] Alternatively, addition of **26** to a --78 °C solution of Ti(Me)~4~ in dichloromethane,[@cit19] which was prepared *in situ* by combining MeLi and TiCl~4~ in a 4 : 1 ratio, provided the desired diastereomer **28** in 60% yield and 9 : 1 dr. We hypothesize that the divergent diastereoselectivity for these two reactions resulted from the different methylating reagents, (^i^PrO)~3~TiMe or Ti(Me)~4~, prepared *in situ*. One possible explanation is that **27** formed by ligand exchange of the carboxylic acid of **26** with (^i^PrO)~3~TiMe followed by intramolecular delivery of the methyl nucleophile, while **28** resulted from addition of Ti(Me)~4~ without the assistance of chelation.

To complete the synthesis, **28** was reduced under standard hydrogenation conditions. Decarboxylative Giese addition of **28** to methyl vinyl ketone under photoredox catalysis provided (+)-rumphellaone A (**8**) in good yield, completing the synthesis in 9 steps from commercially available material. Epimeric acid **27** could be analogously elaborated to (+)-*epi*-C8-rumphellaone A (**29**).

Conclusions
===========

Through a strategy for difunctionalization, we have demonstrated that 8-aminoquinolinamide **4** can serve as a valuable building block for the synthesis of enantioenriched cyclobutanes. We further illustrated this concept in a 9-step synthesis of (+)-rumphellaone A (**8**). We anticipate that this general strategy could enable the expedient synthesis of additional natural products and other bioactive molecules.
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